Arm and Qualcomm Clash Over Licensing in High-Stakes Trial
The Delaware court case centers on Qualcomm's use of Nuvia's chip designs and could reshape IP licensing and chip industry dynamics.
- The trial focuses on whether Qualcomm's existing license with Arm covers Nuvia's chip designs, acquired in a $1.4 billion deal in 2021.
- Arm argues that Qualcomm violated licensing terms by not renegotiating Nuvia's higher royalty rates and seeks the destruction of Nuvia-based designs.
- Qualcomm contends that its current license suffices and accuses Arm of attempting to stifle competition and raise royalties under financial pressure.
- The case has significant implications for intellectual property rights, mergers, and the broader chip industry, including Windows AI PCs using Qualcomm chips.
- Key witnesses include Arm CEO Rene Haas, Qualcomm CEO Cristiano Amon, and Nuvia founder Gerard Williams, with a verdict expected this week.